JPH0627111B2 - Novel .GAMMA.-L-glutamyl-4-nitroanilide derivative and method for measuring .GAMMA.-GTP activity using the same - Google Patents

Novel .GAMMA.-L-glutamyl-4-nitroanilide derivative and method for measuring .GAMMA.-GTP activity using the same

Info

Publication number
JPH0627111B2
JPH0627111B2 JP63164716A JP16471688A JPH0627111B2 JP H0627111 B2 JPH0627111 B2 JP H0627111B2 JP 63164716 A JP63164716 A JP 63164716A JP 16471688 A JP16471688 A JP 16471688A JP H0627111 B2 JPH0627111 B2 JP H0627111B2
Authority
JP
Japan
Prior art keywords
glutamyl
nitroanilide
gtp
substrate
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63164716A
Other languages
Japanese (ja)
Other versions
JPH01110654A (en
Inventor
博 小方
裕美 名和
邦明 徳田
正巳 石原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Wako Pure Chemical Corp
Original Assignee
Wako Pure Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wako Pure Chemical Industries Ltd filed Critical Wako Pure Chemical Industries Ltd
Priority to JP63164716A priority Critical patent/JPH0627111B2/en
Publication of JPH01110654A publication Critical patent/JPH01110654A/en
Publication of JPH0627111B2 publication Critical patent/JPH0627111B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、γ−グルタミルトランスペプチダーゼ(以
下、γ−GTPと略す。)活性測定用の基質として有用
な、新規なγ−L−グルタミル−4−ニトロアニリド誘
導体及びこれを用いるγ−GTP活性測定方法に関す
る。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention is a novel γ-L-glutamyl-useful substrate for measuring γ-glutamyl transpeptidase (hereinafter abbreviated as γ-GTP) activity. The present invention relates to a 4-nitroanilide derivative and a γ-GTP activity measuring method using the same.

[発明の背景] γ−GTPは、γ−グルタミルペプチドを加水分解しγ
−グルタミル基を他のペプチドやアミノ酸に転移させる
作用をもつ膜結合酵素である。
BACKGROUND OF THE INVENTION γ-GTP hydrolyzes γ-glutamyl peptides to give γ
-A membrane-bound enzyme that acts to transfer a glutamyl group to another peptide or amino acid.

γ−GTP活性の測定は、肝・胆道疾患の診断、アルコ
ール中毒症のスクリーニング等に広く利用されている。
最近では、肝細胞癌患者血清に特異的に出現するγ−G
TPアイソザイムが見出されたり、尿中γ−GTPと病
態との関連が報告される等、γ−GTPの活性測定の診
断的価値が改めて注目されている。
The measurement of γ-GTP activity is widely used for diagnosis of liver / biliary tract diseases, screening for alcoholism and the like.
Recently, γ-G specifically appearing in the serum of patients with hepatocellular carcinoma
The diagnostic value of the activity measurement of γ-GTP is renewed attention, such as the discovery of TP isozyme and the report of the relationship between γ-GTP in urine and pathological conditions.

γ−GTP活性の測定方法としては、これまでに種々の
方法が提案され実用に供されているが、γ−L−グルタ
ミル−p−ニトロアニリドを基質とする反応速度測定法
(レイトアッセイ法)が最も一般的であり、現在も盛ん
に行われている。
As a method for measuring γ-GTP activity, various methods have been proposed and put into practical use so far, but a reaction rate measurement method using γ-L-glutamyl-p-nitroanilide as a substrate (late assay method) Is the most common and is still popular today.

しかしながら、基質のγ−L−グルタミル−p−ニトロ
アニリドはγ−GTPの活性測定に至適なpH範囲では
難溶性で、しかも、ある程度溶解度の得られるpH範囲
では溶解後不安定であるという問題点を有している。
However, the problem that the substrate γ-L-glutamyl-p-nitroanilide is poorly soluble in the optimum pH range for measuring the activity of γ-GTP, and is unstable after dissolution in the pH range where solubility is obtained to some extent Have a point.

一方、これらの点を改良した水溶性基質としてγ−L−
グルタミル−3−カルボキシ−4−ニトロアニリドやγ
−L−グルタミル−3−スルホ−4−ニトロアニリド等
がある(特公昭54−7781号公報)。これらの水溶性基質
は前記γ−L−グルタミル−p−ニトロアニリドと比べ
れば溶解性、溶解後の安定性共に遥かに優れてはいる
が、溶解後の安定性の点に関して言えば必ずしも未だ満
足し得るほど安定であるとは言えず改良の余地が残され
ている。
On the other hand, as a water-soluble substrate with these points improved, γ-L-
Glutamyl-3-carboxy-4-nitroanilide and γ
There are -L-glutamyl-3-sulfo-4-nitroanilide and the like (Japanese Patent Publication No. 54-7781). These water-soluble substrates are far superior in solubility and stability after dissolution as compared with the above-mentioned γ-L-glutamyl-p-nitroanilide, but are still not satisfactory in terms of stability after dissolution. It is not stable enough and there is room for improvement.

また、人血清中のγ−GTPの活性測定を行う場合に、
濃度既知のγ−GTPを含む血清(コントロール血清)
を標準或は精度管理用の指標として用いることがよく行
われるが、このようなコントロール血清に添加されるγ
−GTPとしては、牛腎臓や豚腎臓由来のものが主に用
いられている。即ち、γ−GTP含量の高い人血清中に
は、血清肝炎ウイルスが存在している可能性が高く、こ
れからγ−GTPの精製を行うには衛生上問題があるこ
とや、γ−GTPを多量に含む人組織が人手しにくい等
の理由から代用品として牛腎臓や豚腎臓由来のγ−GT
Pが用いられている訳である。しかしながら、上記した
如き水溶性基質は、γ−L−グルタミル−p−ニトロア
ニリドに比較して強い極性基(水溶性基)を有するた
め、γ−GTPの荷電状態、特に活性部位付近の荷電状
態に応じて基質としての反応性が変化し易く、人肝臓,
牛腎臓,豚腎臓等その由来の異なるγ−GTP毎に、基
質としての反応性がかなり異なる。即ち、上記した如き
種々のγ−GTPを所定のモル濃度溶解したものを試料
とし、上記した如き水溶性基質を用いて、試料中のγ−
GTPの活性値[国際単位(IU)/l]を測定した場
合には、その活性値の差がかなり大きいものとなる。従
って、通常のコントロール血清を標準或は精度管理の指
標として用いて、人血清中のγ−GTPの測定を行う際
に上記した如き水溶性基質を用いた場合には、従来のγ
−L−グルタミル−p−ニトロアニリドを基質として用
いる測定法に比較して、コントロール血清の管理をより
厳密に行う必要があるという欠点があった。
When measuring the activity of γ-GTP in human serum,
Serum containing γ-GTP of known concentration (control serum)
Is often used as a standard or an index for quality control, and γ added to such control serum
As GTP, those derived from bovine kidney or pig kidney are mainly used. That is, there is a high possibility that serum hepatitis virus is present in human serum having a high γ-GTP content, and there is a sanitary problem in purifying γ-GTP from this, and a large amount of γ-GTP is required. Γ-GT derived from bovine kidney or swine kidney as a substitute because human tissues included in
That is, P is used. However, since the water-soluble substrate as described above has a stronger polar group (water-soluble group) than γ-L-glutamyl-p-nitroanilide, the charge state of γ-GTP, especially the charge state in the vicinity of the active site. The reactivity as a substrate easily changes depending on the
Reactivity as a substrate is considerably different for each γ-GTP having different origins such as bovine kidney and pig kidney. That is, a sample prepared by dissolving various γ-GTPs as described above in a predetermined molar concentration is used as a sample, and the water-soluble substrate as described above is used to
When the activity value of GTP [international unit (IU) / l] is measured, the difference between the activity values is considerably large. Therefore, when a water-soluble substrate as described above is used in the measurement of γ-GTP in human serum using normal control serum as a standard or an index for quality control, conventional γ
As compared with the assay method using -L-glutamyl-p-nitroanilide as a substrate, there is a drawback in that control serum needs to be managed more strictly.

[発明の目的] 本発明は、上記した如き状況に鑑みなされたもので、水
溶性で、溶解後の安定性も良く、しかも由来の異なるγ
−GTPによる反応性の差も小さい新規γ−GTP活性
測定用基質とこれを用いるγ−GTP活性測定方法を提
供することを目的とする。
[Object of the Invention] The present invention has been made in view of the above situation, and is water-soluble, has good stability after dissolution, and has a different γ
An object of the present invention is to provide a novel substrate for measuring γ-GTP activity with a small difference in reactivity with GTP and a method for measuring γ-GTP activity using the same.

[発明の構成] 本発明は、一般式 (式中、Rは、2以上の水酸基を有していてもよい低級
ヒドロキシアルキル基を表わす。)で示されるγ−L−
グルタミル−4−ニトロアニリド誘導体及びこれを基質
として用いるγ−GTP活性測定方法の発明である。
[Structure of the Invention] The present invention has the general formula (In the formula, R represents a lower hydroxyalkyl group which may have two or more hydroxyl groups.) Γ-L-
It is an invention of a glutamyl-4-nitroanilide derivative and a method for measuring γ-GTP activity using the same as a substrate.

即ち、本発明者らは、カルボキシル基やスルホン酸基と
異なり著しく極性が弱いヒドロキシアルキル基を水溶性
基としてニトロ基のオルト位に導入した新規なγ−L−
グルタミル−4−ニトロアニリド誘導体を創製し、これ
をγ−GTP活性測定用の基質として用いれば上記問題
点は大幅に解決され、従来にない優れたγ−GTP活性
測定方法の組立が可能となると考え、鋭意研究の結果、
本発明を完成するに至った。
That is, the present inventors have introduced a novel γ-L- group in which a hydroxyalkyl group having a remarkably weak polarity, unlike a carboxyl group or a sulfonic acid group, is introduced at the ortho position of a nitro group as a water-soluble group.
If a glutamyl-4-nitroanilide derivative is created and used as a substrate for γ-GTP activity measurement, the above problems will be greatly solved, and it becomes possible to assemble an unprecedented excellent γ-GTP activity measurement method. As a result of thought and earnest research,
The present invention has been completed.

上記一般式で示される本発明の化合物は、文献未載の新
規化合物である。
The compound of the present invention represented by the above general formula is a novel compound which has not been published in the literature.

本発明新規化合物の特徴は、ニトロ基のオルト位に結合
している水溶性基が、カルボキシル基やスルホン酸基と
違って著しく極性が弱いヒドロキシアルキル基である点
である。
The feature of the novel compound of the present invention is that the water-soluble group bonded to the ortho position of the nitro group is a hydroxyalkyl group having extremely weak polarity unlike the carboxyl group and the sulfonic acid group.

上記一般式で示される本発明化合物に於いて、Rで表わ
される2以上の水溶基を有していてもよい低級ヒドロキ
シアルキル基としては、例えばヒドロキシメチル基、1
−ヒドロキシエチル基,2−ヒドロキシエチル基,1−
ヒドロキシプロピル基,2−ヒドロキシプロピル基,3
−ヒドロキシプロピル基,1,2−ジヒドロキシプロピル
基,1,3−ジヒドロキシプロピル基,2,3−ジヒドロキシ
プロピル基,1,4−ジヒドロキシブチル基,2,3−ジヒド
ロキシブチル基,3,4−ジヒドロキシブチル基等炭素数
1〜4の低級ヒドロキシアルキル基が挙げられる。
In the compound of the present invention represented by the above general formula, examples of the lower hydroxyalkyl group represented by R, which may have two or more water-soluble groups, include hydroxymethyl group and 1
-Hydroxyethyl group, 2-hydroxyethyl group, 1-
Hydroxypropyl group, 2-hydroxypropyl group, 3
-Hydroxypropyl group, 1,2-dihydroxypropyl group, 1,3-dihydroxypropyl group, 2,3-dihydroxypropyl group, 1,4-dihydroxybutyl group, 2,3-dihydroxybutyl group, 3,4-dihydroxy group Examples thereof include a lower hydroxyalkyl group having 1 to 4 carbon atoms such as a butyl group.

本発明化合物は、相当する4−ニトロアニリン誘導体と
N−フタロイル−L−グルタミン酸無水物等カルボキシ
ル基が活性化されたN−保護−L−グルタミン酸とを、
ジオキサン、ジメチルスルホキシド等の有機溶媒中で反
応させ、次いでヒドラジン等でアミノ保護基を脱離させ
ることによって容易に合成することができる。
The compound of the present invention comprises a corresponding 4-nitroaniline derivative and N-protected-L-glutamic acid having a carboxyl group activated such as N-phthaloyl-L-glutamic anhydride.
It can be easily synthesized by reacting in an organic solvent such as dioxane or dimethyl sulfoxide, and then removing the amino protecting group with hydrazine or the like.

中間原料の4−ニトロアニリド誘導体は、相当するアニ
リン誘導体をアシル化後、ニトロ化して目的の位置がニ
トロ化されたN−アシル体を単離し、次いでこれを加水
分解してアシル基を外すことにより容易に合成し得る。
The 4-nitroanilide derivative as an intermediate raw material is obtained by acylating a corresponding aniline derivative and then nitrating to isolate an N-acyl derivative in which a desired position is nitrated, and then hydrolyzing this to remove an acyl group. Can be easily synthesized.

本発明のγ−L−グルタミル−4−ニトロアニリド誘導
体は、ニトロ基のオルト位に低級炭化水素基を介して水
酸基を有しているため水溶解性及び溶解後の安定性に優
れ、また、ヒドロキシアルキル基がカルボキシル基やス
ルホン酸基と違って著しく弱い極性基であるため、γ−
GTPとの反応性が高く、しかも種々の動物由来のγ−
GTPとの反応性の差も小さい等基質として優れた特性
を有し、γ−GTP活性測定用の優れた基質となる。
Since the γ-L-glutamyl-4-nitroanilide derivative of the present invention has a hydroxyl group at the ortho position of the nitro group via a lower hydrocarbon group, it is excellent in water solubility and stability after dissolution, and Unlike the carboxyl group and the sulfonic acid group, the hydroxyalkyl group is a remarkably weak polar group.
Highly reactive with GTP and γ-derived from various animals
It has excellent properties as a substrate such as a small difference in reactivity with GTP, and is an excellent substrate for measuring γ-GTP activity.

本発明のγ−GTP活性測定法は基質に本発明のγ−L
−グルタミル−4−ニトロアニリド誘導体を用いる以外
はγ−グルタミル−p−ニトロアニリドを基質として用
いる自体公知のγ−GTP活性測定法に準じてこれを行
うことで足りる。即ち、本発明のγ−L−グルタミル−
4−ニトロアニリド誘導体を基質として用い、グリシル
グリシン等のグルタミン酸受容体の存在下、人血清、人
尿等の検体と該基質とを適当な緩衝剤中に添加して反応
を行わせ、γ−GTPの酵素作用により生成する4−ニ
トロアニリン誘導体の量を、例えばその吸光度を直接測
定する初速度測定法(レイトアッセイ法等)により、或
はこれにp−ジアルキルアミノベンズアルデヒドやp−
ジアルキルアミノシンナムアルデヒド等を加えて発色さ
せ、その吸光度を測定する方法等により、測定すればよ
く、測定の方法自体は任意である。尚、血清中のアミノ
酸に起因する阻害を一様化する為に、グルタミン酸等の
アミノ酸類を予め試薬中に添加する等は任意である。ま
た、緩衝液、反応液pH、基質及び受容体量、測定温
度、測定波長等の測定条件は常法に従えばよい。
The γ-GTP activity measuring method of the present invention uses the γ-L of the present invention as a substrate.
It is sufficient to carry out this according to a known γ-GTP activity measuring method using γ-glutamyl-p-nitroanilide as a substrate except that a -glutamyl-4-nitroanilide derivative is used. That is, γ-L-glutamyl-of the present invention
Using a 4-nitroanilide derivative as a substrate, in the presence of a glutamate receptor such as glycylglycine, a sample such as human serum or human urine and the substrate are added to an appropriate buffer to cause a reaction, and γ -The amount of the 4-nitroaniline derivative produced by the enzymatic action of GTP can be measured, for example, by an initial rate measuring method (rate assay method or the like) in which its absorbance is directly measured, or by adding p-dialkylaminobenzaldehyde or p-
It may be measured by a method of adding dialkylaminocinnamaldehyde or the like to develop a color and measuring the absorbance, and the measuring method itself is arbitrary. In order to equalize the inhibition caused by amino acids in serum, it is optional to add amino acids such as glutamic acid to the reagent in advance. Further, the measurement conditions such as the buffer solution, the reaction solution pH, the amount of the substrate and the acceptor, the measurement temperature, the measurement wavelength and the like may be according to the conventional method.

本発明基質は、従来γ−GTP活性測定の基質として標
準的に用いられてきたγ−L−グルタミル−p−ニトロ
アニリドやγ−L−グルタミル−3−カルボキシ−4−
ニトロアニリドが各々単独では用い得なかった諸特徴を
兼備し、水溶解性、溶解後の安定性、γ−GTPとの反
応性の全ての面に於いて優れた特性を示し、従来にない
極めて優れたγ−GTP活性測定用の基質として、その
効果を遺憾なく発揮する。
The substrate of the present invention has been conventionally used as a standard substrate for measuring γ-GTP activity, γ-L-glutamyl-p-nitroanilide and γ-L-glutamyl-3-carboxy-4-.
Nitroanilide has various characteristics that could not be used alone, and it has excellent properties in all aspects of water solubility, stability after dissolution, and reactivity with γ-GTP, which is extremely high than ever before. As an excellent substrate for γ-GTP activity measurement, its effect is fully demonstrated.

以下に実施例を示すが、本発明はこれらの実施例によっ
て何等の制約を受けるものではない。
Examples will be shown below, but the present invention is not limited by these examples.

[実施例] 実施例1.γ−L−グルタミル−3−ヒドロキシメチル
−4−ニトロアニリドの合成 3−アミノベンジルアルコール24.6gを無水酢酸81.6g
に溶解し、3時間還流反応させた。反応終了後、常法に
従い後処理して、3−アセトキシメチルアセトアニリド
の結晶34.6gを得た。
[Example] Example 1. Synthesis of γ-L-glutamyl-3-hydroxymethyl-4-nitroanilide 3aminobenzyl alcohol 24.6 g and acetic anhydride 81.6 g
And was refluxed for 3 hours. After completion of the reaction, post-treatment was carried out according to a conventional method to obtain 34.6 g of crystals of 3-acetoxymethylacetanilide.

mp 81〜83℃。mp 81-83 ° C.

無水酢酸300mlに濃硝酸(d=1.42)56gを加え、これ
に上で得られた3−アセトキシメチルアセトアニリド3
2.0gを加えて溶解し、14〜16℃で2時間反応させた。
反応終了後、常法に従って目的物を抽出し、抽出油分3
7.9gをカラムクロマトグラフィーにより精製後、結晶
化させ、3−アセトキシメチル−4−ニトロアセトアニ
リドの結晶9.7gを得た。
56 g of concentrated nitric acid (d = 1.42) was added to 300 ml of acetic anhydride, and 3-acetoxymethylacetanilide 3 obtained above was added to this.
2.0 g was added and dissolved, and reacted at 14 to 16 ° C for 2 hours.
After completion of the reaction, the target product was extracted according to the usual method, and the extracted oil
7.9 g was purified by column chromatography and then crystallized to obtain 9.7 g of 3-acetoxymethyl-4-nitroacetanilide crystals.

mp 110℃。mp 110 ° C.

得られた3−アセトキシメチル−4−ニトロアセトアニ
リド9.7gを2N−塩酸100mlに加温溶解し、0.5時間還
流反応させた後、常法に従い後処理して、3−ヒドロキ
シメチル−4−ニトロアニリドの結晶5.4gを得た。
The obtained 3-acetoxymethyl-4-nitroacetanilide (9.7 g) was dissolved in 100 ml of 2N-hydrochloric acid with heating, and the mixture was refluxed for 0.5 hours and then post-treated according to a conventional method to give 3-hydroxymethyl-4-nitroanilide. 5.4 g of crystals were obtained.

mp 143〜145℃。mp 143-145 ° C.

UV λmax:382nm、ε=1.28×104(H2O)。UV λ max : 382 nm, ε = 1.28 × 10 4 (H 2 O).

IR υcm-1(KBr):3460、3360(NH2))、3250(O
H)、1340(NO2)。
IR υ cm -1 (KBr): 3460, 3360 (NH 2 )), 3250 (O
H), 1340 (NO 2) .

NMR δppm(Acetone-d6):2.95(2H,s,-CH2 OH)、4.50
(1H,d,CH2OH)、6.00(2H,br.,-NH2 )、6.50〜6.90(1H,dd, 7.05〜7.35(1H,d, 7.90〜8.20(1H,d, 得られた3−ヒドロキシメチル−4−ニトロアニリンの
全量にN−フタロイル−L−グルタミン酸無水物11.8g
及びジオキサン30mlを加えて加温溶解し、7時間還流反
応させた。反応終了後、常法に従い後処理して、N−フ
タロイル−γ−L−グルタミル−3−ヒドロキシメチル
−4−ニトロアニリドの結晶11.8gを得た。
NMR δ ppm (Acetone-d 6 ): 2.95 (2H, s, -C H 2 OH), 4.50
(1H, d, CH 2 O H ), 6.00 (2H, br.,-N H 2 ), 6.50 to 6.90 (1H, dd, 7.05 ~ 7.35 (1H, d, 7.90-8.20 (1H, d, 11.8 g of N-phthaloyl-L-glutamic anhydride was added to the total amount of 3-hydroxymethyl-4-nitroaniline obtained.
And 30 ml of dioxane were added and dissolved by heating, and the mixture was refluxed for 7 hours. After completion of the reaction, post-treatment was carried out according to a conventional method to obtain 11.8 g of crystals of N-phthaloyl-γ-L-glutamyl-3-hydroxymethyl-4-nitroanilide.

mp 211〜213℃。mp 211-213 ° C.

得られたN−フタロイル−γ−L−グルタミル−3−ヒ
ドロキシメチル−4−ニトロアニリドの全量に、メタノ
ール140mlを加えて溶解し、80%抱水ヒドラジン4.6gを
加え、17〜20℃で5時間撹拌後、一夜放置した。反応終
了後、常法に従い後処理して、γ−L−グルタミル−3
−ヒドロキシメチル−4−ニトロアニリドの結晶5.7g
を得た。
To the total amount of the obtained N-phthaloyl-γ-L-glutamyl-3-hydroxymethyl-4-nitroanilide, 140 ml of methanol was added and dissolved, 4.6 g of 80% hydrazine hydrate was added, and the mixture was heated at 17 to 20 ° C. for 5 minutes. After stirring for an hour, it was left overnight. After completion of the reaction, post-treatment was carried out according to a conventional method to give γ-L-glutamyl-3.
5.7 g of crystals of hydroxymethyl-4-nitroanilide
Got

mp 156℃(dec)。mp 156 ° C (dec).

UV λmax:317nm、ε=1.01×104(H2O)。UV λ max : 317 nm, ε = 1.01 × 10 4 (H 2 O).

IR υcm-1(KBr):3400(NH,NH2)、3230(OH)、16
80(CO)、1620(COOH)、1320,1500(NO2)。
IR υcm -1 (KBr): 3400 (NH, NH 2 ), 3230 (OH), 16
80 (CO), 1620 (COOH), 1320,1500 (NO 2 ).

NMR δppm(DMSO-d6):1.7〜2.3(2H,br.,-CHCH2 CH
2-)、2.3〜3.0(2H,br.,-CHCH2CH2 -)、3.1〜3.7(1H,br.,
-CHCH2CH2-)、4.8(2H,s,-CH2 OH)、5.5〜8.0(4H,br.,N
H2 ,CONH,OH)、7.5〜8.2(3H,m,phenyl)、10.5〜11.5(1H,
br.,-COOH)。
NMR δ ppm (DMSO-d 6 ): 1.7 to 2.3 (2H, br., -CHC H 2 CH
2- ), 2.3 to 3.0 (2H, br.,-CHCH 2 C H 2- ), 3.1 to 3.7 (1H, br.,
-C H CH 2 CH 2- ), 4.8 (2H, s, -C H 2 OH), 5.5 ~ 8.0 (4H, br., N
H 2, CON H, O H ), 7.5~8.2 (3H, m, phenyl), 10.5~11.5 (1H,
br.,-COO H ).

実施例2.γ−L−グルタミル−3−(α−ヒドロキシ
エチル)−4−ニトロアニリドの合成 3−(α−ヒドロキシエチル)アニリン12.3gを無水酢
酸35mlに溶解し、105〜110℃で1.5時間反応させた。反
応終了後、常法に従って目的物を抽出し、3−(α−ア
セトキシエチル)アセトアニリドを含む油分20gを得
た。
Example 2. Synthesis of γ-L-glutamyl-3- (α-hydroxyethyl) -4-nitroanilide 12.3 g of 3- (α-hydroxyethyl) aniline was dissolved in 35 ml of acetic anhydride and reacted at 105 to 110 ° C for 1.5 hours. . After completion of the reaction, the target product was extracted according to a conventional method to obtain 20 g of an oil containing 3- (α-acetoxyethyl) acetanilide.

得られた油分19gに無水酢酸100mlを加え、これに濃硝
酸(d=1.42)21mlを0〜10℃で加え、同温度で4時間
反応させた。反応終了後、常法に従って目的物を抽出
し、抽出油分19gからカラムクロマトグラフィーにより
3−(α−アセトキシエチル)−4−ニトロアセトアニ
リドの油分1.8gを得た。
100 ml of acetic anhydride was added to 19 g of the obtained oil, 21 ml of concentrated nitric acid (d = 1.42) was added thereto at 0 to 10 ° C., and the reaction was carried out at the same temperature for 4 hours. After completion of the reaction, the desired product was extracted by a conventional method, and 1.8 g of 3- (α-acetoxyethyl) -4-nitroacetanilide oil was obtained from 19 g of the extracted oil by column chromatography.

得られた3−(α−アセトキシエチル)−4−ニトロア
セトアニリドの全量に2N−塩酸10ml加えて加温溶解
し、99〜101℃で1時間反応させた。反応終了後、常法
に従って目的物を抽出し、3−(α−ヒドロキシエチ
ル)−4−ニトロアニリンの油分1.1gを得た。
To the total amount of the obtained 3- (α-acetoxyethyl) -4-nitroacetanilide, 10 ml of 2N-hydrochloric acid was added and dissolved by heating, and the mixture was reacted at 99 to 101 ° C for 1 hour. After completion of the reaction, the desired product was extracted by a conventional method to obtain 1.1 g of 3- (α-hydroxyethyl) -4-nitroaniline oil.

UV λmax:380nm、ε=0.96×104(H2O)。UV λ max : 380 nm, ε = 0.96 × 10 4 (H 2 O).

NMR δppm(DMSO-d6):1.55(3H,d,-CH3 )、5.0(1H,m,
-OH)、5.3〜5.7(1H,m, 5.8〜6.3(2H,m,-NH2 )、6.5(1H,dd, J=18Hz,3Hz)、7.2(1H,d, J=3Hz)、7.8(1H,d, J=18Hz)。
NMR δ ppm (DMSO-d 6 ): 1.55 (3H, d, -C H 3 ), 5.0 (1H, m,
-O H ), 5.3 to 5.7 (1H, m, 5.8 ~ 6.3 (2H, m, -N H 2 ), 6.5 (1H, dd, J = 18Hz, 3Hz), 7.2 (1H, d, J = 3Hz), 7.8 (1H, d, J = 18Hz).

得られた3−(α−ヒドロキシエチル)−4−ニトロア
ニリン1.1gにN−フタロイル−L−グルタミン酸無水
物1.9g及びジオキサン20mlを加えて加温溶解し、90〜9
5℃で3.5時間反応させた。反応終了後、常法に従い後処
理して、N−フタロイル−γ−グルタミル−3−(α−
ヒドロキシエチル)−4−ニトロアニリドの粘性油分2.
7gを得た。
To 1.1 g of the obtained 3- (α-hydroxyethyl) -4-nitroaniline, 1.9 g of N-phthaloyl-L-glutamic anhydride and 20 ml of dioxane were added and dissolved by heating to 90-9
The reaction was carried out at 5 ° C for 3.5 hours. After completion of the reaction, post-treatment was performed according to a conventional method to give N-phthaloyl-γ-glutamyl-3- (α-
Viscous oil of hydroxyethyl) -4-nitroanilide 2.
7 g was obtained.

得られたN−フタロイル−γ−L−グルタミル−3−
(α−ヒドロキシエチル)−4−ニトロアニリドの全量
に、メタノール30mlを加えて溶解し、80%抱水ヒドラジ
ン0.5mlを加え、18〜20℃で4時間撹拌後、一夜放置し
た。反応終了後、常法に従い後処理して、γ−L−グル
タミル−3−(α−ヒドロキシエチル)−4−ニトロア
ニリドの結晶0.5gを得た。
Obtained N-phthaloyl-γ-L-glutamyl-3-
To the whole amount of (α-hydroxyethyl) -4-nitroanilide, 30 ml of methanol was added and dissolved, 0.5 ml of 80% hydrazine hydrate was added, and the mixture was stirred at 18 to 20 ° C. for 4 hours and then left overnight. After completion of the reaction, post-treatment was carried out according to a conventional method to obtain 0.5 g of crystals of γ-L-glutamyl-3- (α-hydroxyethyl) -4-nitroanilide.

mp 160℃(dec)。mp 160 ° C (dec).

UV λmax:306nm、ε=0.52×104(H2O)。UV λ max : 306 nm, ε = 0.52 × 10 4 (H 2 O).

NMR δppm(DMSO-d6):1.35(3H,d,-CH3 )、1.5〜3.0
(4H,m, 3.0〜3.5(1H,m, 4.5〜6.2(6H,br.,-COOH,-NH2 , 7.8〜8.2(3H,m,phenyl)。
NMR δ ppm (DMSO-d 6 ): 1.35 (3H, d, -C H 3 ), 1.5 to 3.0
(4H, m, 3.0 to 3.5 (1H, m, 4.5 ~ 6.2 (6H, br.,-COO H , -N H 2 , 7.8-8.2 (3H, m, phenyl).

実施例3.γ−L−グルタミル−3−(β−ヒドロキシ
エチル)−4−ニトロアニリドの合成 3−(β−ヒドロキシエチル)アニリン10.3gを無水酢
酸30mlに溶解し、109〜112℃で0.5時間反応させた。反
応終了後、常法に従って目的物を抽出し、3−(β−ア
セトキシエチル)アセトアニリドを含む油分17.2gを得
た。
Example 3. Synthesis of γ-L-glutamyl-3- (β-hydroxyethyl) -4-nitroanilide 10.3 g of 3- (β-hydroxyethyl) aniline was dissolved in 30 ml of acetic anhydride and reacted at 109-112 ° C for 0.5 hours. . After completion of the reaction, the target product was extracted by a conventional method to obtain 17.2 g of an oil containing 3- (β-acetoxyethyl) acetanilide.

無水酢酸140mlに濃硝酸(d=1.42)27gを加え、これ
に上で得られた3−(β−アセトキシエチル)アセトア
ニリド17.0gを無水酢酸15mlに溶かした溶液を加え、14
〜16℃で2時間反応させた。反応終了後、常法に従って
目的物を抽出し、抽出油分18gをカラムクロマトグラフ
ィーにより精製結晶化させ、3−(β−アセトキシエチ
ル)−4−ニトロアセトアニリドの結晶1.7gを得た。
To 140 ml of acetic anhydride was added 27 g of concentrated nitric acid (d = 1.42), and to this was added a solution of 17.0 g of 3- (β-acetoxyethyl) acetanilide obtained above in 15 ml of acetic anhydride.
Reacted for 2 hours at -16 ° C. After completion of the reaction, the target product was extracted by a conventional method, and 18 g of the extracted oil was purified and crystallized by column chromatography to obtain 1.7 g of 3- (β-acetoxyethyl) -4-nitroacetanilide crystals.

mp 137〜139℃。mp 137-139 ° C.

得られた3−(β−アセトキシエチル)−4−ニトロア
セトアニリド1.6gを2N−塩酸16ml加えて加温溶解
し、99〜101℃で0.5時間反応させた。反応終了後、常法
に従って目的物を抽出精製し、3−(β−ヒドロキシエ
チル)−4−ニトロアニリドの結晶0.88gを得た。
1.6 g of the obtained 3- (β-acetoxyethyl) -4-nitroacetanilide was added to 16 ml of 2N-hydrochloric acid and dissolved by heating, and reacted at 99 to 101 ° C. for 0.5 hours. After completion of the reaction, the desired product was extracted and purified by a conventional method to obtain 0.88 g of crystals of 3- (β-hydroxyethyl) -4-nitroanilide.

mp 95〜96℃。mp 95-96 ° C.

UV λmax:381nm、ε=1.09×104(H2O)。UV λ max : 381 nm, ε = 1.09 × 10 4 (H 2 O).

IR υcm-1(KBr):3460(OH)、3230,3350(NH2)、
1305(NO2)。
IR υcm -1 (KBr): 3460 (OH), 3230, 3350 (NH 2 ),
1305 (NO 2 ).

NMR δppm(CDCl3+DMSO-d6):3.2(2H,t,-CH2 OH)、3.
8(1H,br.,-OH)、3.9(2H,t,-CH2CH2 OH)、5.3(2H,br.,-NH
2 )、6.4〜8.1(3H,m,phenyl)。得られた3−(β−ヒド
ロキシエチル)−4−ニトロアニリン0.80gにN−フタ
ロイル−L−グルタミン酸無水物1.59g及びジオキサン
15mlを加えて加温溶解し、95℃で4時間反応させた。反
応終了後、常法に従い、カラムクロマトグラフィーによ
り精製した後、結晶化させ、N−フタロイル−γ−L−
グルタミル−3−(β−ヒドロキシエチル)−4−ニト
ロアニリドの結晶1.4gを得た。
NMR δ ppm (CDCl 3 + DMSO-d 6 ): 3.2 (2H, t, -C H 2 OH), 3.
8 (1H, br.,-O H ), 3.9 (2H, t, -CH 2 C H 2 OH), 5.3 (2H, br.,-N H
2 ), 6.4-8.1 (3H, m, phenyl). 0.80 g of the obtained 3- (β-hydroxyethyl) -4-nitroaniline was added to 1.59 g of N-phthaloyl-L-glutamic anhydride and dioxane.
15 ml was added and dissolved by heating and reacted at 95 ° C. for 4 hours. After completion of the reaction, the product was purified by column chromatography according to a conventional method and then crystallized to give N-phthaloyl-γ-L-
1.4 g of crystals of glutamyl-3- (β-hydroxyethyl) -4-nitroanilide were obtained.

mp 70〜95℃。mp 70-95 ° C.

得られたN−フタロイル−γ−L−グルタミル−3−
(β−ヒドロキシエチル)−4−ニトロアニリド1.3g
に、メタノール15mlを加えて溶解し、80%抱水ヒドラジ
ン0.5gを加え、24〜26℃で5時間撹拌後、一夜放置し
た。反応終了後、常法に従い後処理して、γ−L−グル
タミル−3−(β−ヒドロキシエチル)−4−ニトロア
ニリドの結晶0.52gを得た。
Obtained N-phthaloyl-γ-L-glutamyl-3-
(Β-hydroxyethyl) -4-nitroanilide 1.3 g
15 ml of methanol was added to and dissolved, 0.5 g of 80% hydrazine hydrate was added, and the mixture was stirred at 24-26 ° C for 5 hours and then left overnight. After completion of the reaction, post-treatment was carried out according to a conventional method to obtain 0.52 g of crystals of γ-L-glutamyl-3- (β-hydroxyethyl) -4-nitroanilide.

mp 164〜167℃。mp 164-167 ° C.

UV λmax:309nm、ε=0.816×104(H2O)。UV λ max : 309 nm, ε = 0.816 × 10 4 (H 2 O).

IR υcm-1(KBr):3450(OH)、3320,3250(NH2)、
1680(CONH)、1620(COOH)、1345,1505(NO2)。
IR υ cm -1 (KBr): 3450 (OH), 3320,3250 (NH 2 ),
1680 (CONH), 1620 (COOH), 1345, 1505 (NO 2 ).

NMR δppm(DMSO-d6):1.8〜2.4(2H,br.,-CHCH2 CH
2-)、2.4〜2.9(2H,br.,-CHCH2CH2 -)、2.9〜3.3(2H,t,-C
H2 CH2OH)、3.3〜3.9(3H,m,-CH2CH2 OH,-CHCH2CH2-)、5.5
〜8.0(5H,br.,NH2 ,-COOH,-CONH-,-CH2CH2OH)、7.5〜8.1
(3H,m,phenyl)。
NMR δ ppm (DMSO-d 6 ): 1.8 to 2.4 (2H, br., -CHC H 2 CH
2- ), 2.4 to 2.9 (2H, br.,-CHCH 2 C H 2- ), 2.9 to 3.3 (2H, t, -C
H 2 CH 2 OH), 3.3 to 3.9 (3H, m, -CH 2 C H 2 OH, -C H CH 2 CH 2- ), 5.5
~ 8.0 (5H, br., N H 2 , -COO H , -CON H -,-CH 2 CH 2 O H ), 7.5 ~ 8.1
(3H, m, phenyl).

実施例4.γ−L−グルタミル−3−ヒドロキシメチル
−4−ニトロアニリドの合成 3−アミノベンジルアルコール24.6gを無水酢酸81.6g
に溶解し、3時間還流反応させた。反応終了後、常法に
従い後処理して、3−アセトキシメチルアセトアニリド
の結晶34.6gを得た。
Example 4. Synthesis of γ-L-glutamyl-3-hydroxymethyl-4-nitroanilide 3aminobenzyl alcohol 24.6 g and acetic anhydride 81.6 g
And was refluxed for 3 hours. After completion of the reaction, post-treatment was carried out according to a conventional method to obtain 34.6 g of crystals of 3-acetoxymethylacetanilide.

氷酢酸150ml及び濃硫酸150mlの混液に濃硝酸(d=1.4
2)56gを加え、これに上で得られた3−アセトキシメ
チルアセトアニリド32.0gを液を加えて溶解し、5〜10
℃で2時間反応させた。反応終了後、常法に従って目的
物を抽出し、抽出油分57.5gをトルエン700mlより再結
晶させて、3−アセトキシメチル−4−ニトロアセトア
ニリドの結晶17.5gを得た。
A mixture of 150 ml of glacial acetic acid and 150 ml of concentrated sulfuric acid was added to concentrated nitric acid (d = 1.4
2) 56 g was added, and 32.0 g of 3-acetoxymethylacetanilide obtained above was added to the solution and dissolved,
The reaction was carried out at 0 ° C for 2 hours. After completion of the reaction, the target product was extracted by a conventional method, and 57.5 g of the extracted oil was recrystallized from 700 ml of toluene to obtain 17.5 g of crystals of 3-acetoxymethyl-4-nitroacetanilide.

得られた3−アセトキシメチル−4−ニトロアセトアニ
リド17.5gを2N−塩酸180mlに加温溶解し、0.5時間還
流反応させた後、常法に従い後処理して、3−ヒドロキ
シメチル−4−ニトロアニリドの結晶9.7gを得た。
17.5 g of the obtained 3-acetoxymethyl-4-nitroacetanilide was dissolved in 180 ml of 2N-hydrochloric acid with heating, and the mixture was refluxed for 0.5 hours and then subjected to post-treatment according to a conventional method to give 3-hydroxymethyl-4-nitroanilide. 9.7 g of crystals were obtained.

得られた3−ヒドロキシメチル−4−ニトロアニリドの
全量にN−フタロイル−L−グルタミル酸無水物21.3g
及びジオキサン55mlを加えて加温溶解し、7時間還流反
応させた。反応終了後、常法に従い後処理して、N−フ
タロイル−γ−L−グルタミル−3−ヒドロキシメチル
−4−ニトロアニリドの結晶21.3gを得た。
21.3 g of N-phthaloyl-L-glutamyl anhydride was added to the total amount of 3-hydroxymethyl-4-nitroanilide obtained.
And 55 ml of dioxane were added and dissolved by heating, and the mixture was refluxed for 7 hours. After completion of the reaction, post-treatment was carried out according to a conventional method to obtain 21.3 g of N-phthaloyl-γ-L-glutamyl-3-hydroxymethyl-4-nitroanilide crystals.

得られたN−フタロイル−γ−L−グルタミル−3−ヒ
ドロキシメチル−4−ニトロアニリドの全量に、メタノ
ール250mlを加えて溶解し、80%抱水ヒドラジン8.3gを
加え、17〜20℃で5時間撹拌後、一夜放置した。反応終
了後、常法に従い後処理して、γ−L−グルタミル−3
−ヒドロキシメチル−4−ニトロアニリドの結晶10.3g
を得た。
To the total amount of the obtained N-phthaloyl-γ-L-glutamyl-3-hydroxymethyl-4-nitroanilide, 250 ml of methanol was added and dissolved, and 8.3 g of 80% hydrazine hydrate was added, and the mixture was heated at 17 to 20 ° C. for 5 minutes. After stirring for an hour, it was left overnight. After completion of the reaction, post-treatment was carried out by a conventional method to give γ-L-glutamyl-3.
-Hydroxymethyl-4-nitroanilide crystals 10.3 g
Got

尚、得られた各化合物の物性は、実施例1で得られたも
のと同様であった。
The physical properties of the obtained compounds were the same as those obtained in Example 1.

実施例5.γ−GTP活性の測定 (試薬の調製) 緩衝液 トリス(ヒドロキシメチル)アミノメタン100mmol及び
グリシルグリシン60mmolを精製水800mlに添加し、これ
らに塩酸の適量を加えてpHを8.2(at25℃)とし、精
製水で全量1lとした。
Example 5. Measurement of γ-GTP activity (Preparation of reagents) Buffer solution Tris (hydroxymethyl) aminomethane 100 mmol and glycylglycine 60 mmol were added to purified water 800 ml, and an appropriate amount of hydrochloric acid was added thereto to adjust pH to 8.2 (at 25 ° C). The total volume was adjusted to 1 liter with purified water.

基質液 実施例1で得られたγ−L−グルタミル−3−ヒドロキ
シメチル−4−ニトロアニリド15mmolを精製水に溶解し
全量1lとした。
Substrate solution 15 mmol of γ-L-glutamyl-3-hydroxymethyl-4-nitroanilide obtained in Example 1 was dissolved in purified water to make a total amount of 1 liter.

(試料) 人血清及び、豚腎臓若しくは牛腎臓由来のγ−GTPを
添加した7%牛アルブミン水溶液(以下、夫々を豚試料
及び牛試料と略記する。)を試料とした。
(Sample) Human serum and a 7% bovine albumin aqueous solution to which γ-GTP derived from pig kidney or bovine kidney was added (hereinafter, abbreviated as pig sample and bovine sample, respectively) were used as samples.

(測定方法) 試料50μlに緩衝液2.0mlを加えて37℃3分間予備加
温し、これに基質液0.5mlを加え、良く混合して1分
間放置した後、410nmの吸光度の増加率を測定して、
生成した3−ヒドロキシメチル−4−ニトロアニリンの
分子吸光係数(7.6×106cm2/mol)から試料中のγ−G
TP活性値(IU/1)を算出した。
(Measurement method) Add 2.0 ml of buffer solution to 50 μl of sample, preheat at 37 ° C for 3 minutes, add 0.5 ml of substrate solution, mix well and leave for 1 minute, then measure the rate of increase in absorbance at 410 nm do it,
From the molecular extinction coefficient (7.6 × 10 6 cm 2 / mol) of the produced 3-hydroxymethyl-4-nitroaniline, γ-G in the sample
The TP activity value (IU / 1) was calculated.

実施例6 γ−GTP活性の測定 (試液の調製) 緩衝液 トリス(ヒドロキシメチル)アミノメタン100mmol及び
グリシルグリシン60mmolを精製水800mlに添加し、これ
に塩酸を加えてpHを8.2(at25℃)とした後、精製水
で全量1lとした。
Example 6 Measurement of γ-GTP activity (Preparation of test solution) Buffer solution Tris (hydroxymethyl) aminomethane 100 mmol and glycylglycine 60 mmol were added to purified water 800 ml, and hydrochloric acid was added thereto to adjust pH to 8.2 (at 25 ° C.). After that, the total volume was adjusted to 1 liter with purified water.

基質液 実施例3で得られたγ−L−グルタミル−3−(β−ヒ
ドロキシエチル)−4−ニトロアニリド15mmolを精製水
に溶解し全量1lとした。
Substrate solution 15 mmol of γ-L-glutamyl-3- (β-hydroxyethyl) -4-nitroanilide obtained in Example 3 was dissolved in purified water to make a total amount of 1 liter.

(試料) 実施例5と同じ試料を用いた。(Sample) The same sample as in Example 5 was used.

(測定方法) 試料50μlに緩衝液2.0mlを加えて37℃で3分間予備
加温し、これに基質液0.5mlを加え、良く混合して1
分間放置した後、410nmの吸光度の増加率を測定して、
生成した3−(β−ヒドロキシエチル)−4−ニトロア
ニリンの分子吸光係数(7.3×106cm2/mol)から試料中
のγ−GTP活性値(IU/l)を算出した。
(Measurement method) 2.0 ml of buffer solution was added to 50 μl of sample and pre-heated at 37 ° C. for 3 minutes, 0.5 ml of substrate solution was added thereto, and mixed well 1
After leaving for a minute, measure the increase rate of absorbance at 410 nm,
The γ-GTP activity value (IU / l) in the sample was calculated from the molecular extinction coefficient (7.3 × 10 6 cm 2 / mol) of the produced 3- (β-hydroxyethyl) -4-nitroaniline.

比較例1.γ−GTP活性の測定 (試液の調製) 緩衝液 トリス(ヒドロキシメチル)アミノメタン100mmol及び
グリシルグリシン60mmolを精製水800mlに添加し、これ
に塩酸を加えてpHを8.4(at25℃)とし、精製水で全
量1lとした。
Comparative Example 1. Measurement of γ-GTP activity (Preparation of sample solution) Buffer solution Tris (hydroxymethyl) aminomethane 100 mmol and glycylglycine 60 mmol were added to purified water 800 ml, and hydrochloric acid was added to this to adjust the pH to 8.4 (at 25 ° C), and then purified. The total volume was 1 liter with water.

基質液 γ−L−グルタミル−p−ニトロアニリド20mmolを1N
−硫酸100mlに溶解し、精製水で全量1lにメスアップ
した。
Substrate solution γ-L-glutamyl-p-nitroanilide 20 mmol 1N
-Dissolved in 100 ml of sulfuric acid and made up to a total volume of 1 l with purified water.

尚、上記試液の組成は、γ−GTP B−ARII(和光
純薬工業(株)社商品名)の各試液の組成に準じた。
The composition of the above-mentioned test solution was in accordance with the composition of each test solution of γ-GTP B-ARII (trade name of Wako Pure Chemical Industries, Ltd.).

(試料) 実施例5と同じ試料を用いた。(Sample) The same sample as in Example 5 was used.

(測定方法) 試料50μlに緩衝液2.0mlを加えて37℃で3分間予備
加温し、これに基質液0.5mlを加え、良く混合して1
分間放置した後、410nmの吸光度の増加率を測定し
て、生成したp−ニトロアニリンの分子吸光係数(8.8
×106cm2/mol)から試料中のγ−GTP活性値(IU
/l)を算出した。
(Measurement method) 2.0 ml of buffer solution was added to 50 μl of sample and pre-heated at 37 ° C. for 3 minutes, 0.5 ml of substrate solution was added thereto, and mixed well 1
After standing for a minute, the rate of increase in absorbance at 410 nm was measured, and the molecular extinction coefficient (8.8 of the p-nitroaniline produced was measured.
Γ-GTP activity value (IU) in the sample from × 10 6 cm 2 / mol)
/ L) was calculated.

比較例2.γ−GTP活性の測定 (試液の調製) 緩衝液 トリス(ヒドロキシメチル)アミノメタン100mmol及び
グリシルグリシン100mmolを精製水800mlに添加し、これ
に塩酸を加えてpH8.2(at25℃)とし、精製水で全量
1lとした。
Comparative example 2. Measurement of γ-GTP activity (Preparation of test solution) Buffer solution Add 100 mmol of tris (hydroxymethyl) aminomethane and 100 mmol of glycylglycine to 800 ml of purified water, and add hydrochloric acid to adjust the pH to 8.2 (at 25 ° C) and purify. The total volume was 1 liter with water.

基質液 γ−L−グルタミル−3−カルボキシ−4−ニトロアニ
リドアンモニウム塩14.5mmolを100mMグリシルグリシン
緩衝液(pH8.2)に溶解して全量1lとした。
Substrate solution 14.5 mmol of γ-L-glutamyl-3-carboxy-4-nitroanilide ammonium salt was dissolved in 100 mM glycylglycine buffer solution (pH 8.2) to make a total volume of 1 liter.

尚、上記試液の組成は、γ−GT試薬1及び2(ベーリ
ンガー・マンハイム山之内(株)社商品名)の各組成に
準じた。
The composition of the reagent solution was in accordance with the compositions of γ-GT reagents 1 and 2 (trade name of Boehringer Mannheim Yamanouchi Co., Ltd.).

(試料) 実施例5と同じ試料を用いた。(Sample) The same sample as in Example 5 was used.

(測定方法) 試料50μlに緩衝液2.0mlを加えて37℃で3分間予備
加温し、これに基質液0.5mlを加え、良く混合して1
分間放置した後、410nmの吸光度の増加率を測定し
て、生成した3−カルボキシ−4−ニトロアニリンの分
子吸光係数(7.9×106cm2/mol)から試料中のγ−GT
P活性値(IU/l)を算出した。
(Measurement method) 2.0 ml of buffer solution was added to 50 μl of sample and pre-heated at 37 ° C. for 3 minutes, 0.5 ml of substrate solution was added thereto, and mixed well 1
After leaving for a minute, the rate of increase in absorbance at 410 nm was measured, and the molecular extinction coefficient (7.9 × 10 6 cm 2 / mol) of 3-carboxy-4-nitroaniline produced was used to determine γ-GT in the sample.
The P activity value (IU / l) was calculated.

実施例5及び6、並びに比較例1及び2で得られた結果
を表1に示す。
The results obtained in Examples 5 and 6 and Comparative Examples 1 and 2 are shown in Table 1.

尚、表中の数値は、反応開始後5分間の410nmに於け
る吸光度変化(ΔE/5min)を基に算出した各場合の
γ−GTP活性値(IU/l)を比較例1の場合のそれ
を夫々100としたときの相対的な値で示してある。ま
た、活性相対値差は夫々の基質についての各試料に於け
る相対活性値の最大値と最小値の差である。
The numerical values in the table are the γ-GTP activity values (IU / l) in each case calculated based on the change in absorbance (ΔE / 5 min) at 410 nm for 5 minutes after the reaction was started. It is shown as a relative value when each is set to 100. Further, the difference in the relative activity value is the difference between the maximum value and the minimum value of the relative activity value in each sample for each substrate.

次に、実施例5及び6、並びに比較例1及び2で用いた
γ−GTP活性測定用基質の測定試液(各場合の緩衝液
と基質液を4:1の比率で混合して得られる試液)に於
ける溶解度及び各場合の基質液の安定性試験の結果を表
2に示す。
Next, a measurement reagent solution for the substrate for measuring γ-GTP activity used in Examples 5 and 6 and Comparative Examples 1 and 2 (a reagent solution obtained by mixing the buffer solution and the substrate solution in each case at a ratio of 4: 1). Table 2 shows the results of the solubility test in () and the stability test of the substrate solution in each case.

また、本発明化合物であるγ−L−グルタミル−3−ヒ
ドロキシメチル−4−ニトロアニリドの、人血清,豚腎
臓,牛腎臓由来の各γ−GTPに対するKm値を常法によ
り求めた結果を表3に示す。
In addition, the Km value of γ-L-glutamyl-3-hydroxymethyl-4-nitroanilide, which is the compound of the present invention, for each γ-GTP derived from human serum, porcine kidney, and bovine kidney is shown by a conventional method. 3 shows.

尚、表3には、参考のために、Leslie M.Shawの発表(C
linical Chemistry,23,79頁,1977)した、γ−L−グ
ルタミル−3−カルボキシ−4−ニトロアニリド及びγ
−L−グルタミル−p−ニトロアニリドのKm値も併せて
示す。
For reference, Table 3 shows the presentation of Leslie M. Shaw (C
linical Chemistry, 23 , 79, 1977), γ-L-glutamyl-3-carboxy-4-nitroanilide and γ.
The Km value of -L-glutamyl-p-nitroanilide is also shown.

表1、2及び3から明らかなように、本発明化合物は、
基質としてのγ−GTPとの反応性も良く、しかも由来
の異なるγ−GTPとの反応性の差もかなり小さいこと
が判る。
As is clear from Tables 1, 2 and 3, the compounds of the present invention are
It can be seen that the reactivity with γ-GTP as a substrate is good, and the difference in reactivity with γ-GTP from different origin is quite small.

また、表3の結果から、由来の異なるγ−GTPとの反
応性は、γ−L−グルタミル−3−カルボキシ−4−ニ
トロアニリドの様に比較的極性の強い水溶性基を有する
基質の方が、水溶性基を有さないγ−L−グルタミル−
p−ニトロアニリド或は極性の弱い水溶性基(ヒドロキ
シアルキル基)を有する本発明化合物の如き基質より
も、γ−GTPの由来による差が大きいことが判る。こ
れは、基質と酵素が反応する場合に、相互の荷電状態に
大きく影響されるためではないかと推定される。即ち、
酵素の荷電状態、特に活性部位付近の荷電状態がその由
来によって異なることにより、極性の強い水溶性基を有
する基質の場合には各酵素との反応性が大きく影響を受
けるためであると考えられる。
In addition, from the results in Table 3, the reactivity with γ-GTP of different origin was found to be higher in the case of γ-L-glutamyl-3-carboxy-4-nitroanilide having a relatively polar substrate having a water-soluble group. However, γ-L-glutamyl-having no water-soluble group
It can be seen that the difference due to the origin of γ-GTP is larger than that of the substrate such as the compound of the present invention having p-nitroanilide or a water-soluble group (hydroxyalkyl group) having weak polarity. It is presumed that this is because when the substrate and the enzyme react with each other, they are greatly influenced by the mutual charge states. That is,
It is considered that the reactivity with each enzyme is greatly affected in the case of a substrate having a highly polar water-soluble group because the charge state of the enzyme, especially the charge state near the active site, differs depending on its origin. .

本発明基質の水に対する溶解性は実用上必要な5mmol以
上の溶解度を優に示し、基質液は室温(20〜25℃)保存
の場合も冷蔵(5℃)保存の場合も従来の基質と比べて
遥かに安定であり、冷蔵保存の場合には、少なくとも三
ヵ月間、実用上何ら支障なくこれを使用することができ
る。
The solubility of the substrate of the present invention in water is significantly higher than the practically required solubility of 5 mmol or more, and the substrate solution is stored at room temperature (20 to 25 ° C) or refrigerated (5 ° C) as compared with the conventional substrate. It is much more stable and can be used practically without any problem for at least 3 months in the case of refrigerated storage.

実施例7.(試液の調製) 緩衝液(R1) 実施例5で調製したものを使用した。Example 7. (Preparation of reagent solution) Buffer solution (R1) The one prepared in Example 5 was used.

基質液(R2) 実施例4で得られたγ−L−グルタミル−3−ヒドロキ
シメチル−4−ニトロアニリド10mmolを精製水に溶解し
全量1lとした。
Substrate solution (R2) 10 mmol of γ-L-glutamyl-3-hydroxymethyl-4-nitroanilide obtained in Example 4 was dissolved in purified water to make a total amount of 1 liter.

(試料) 人血清50検体を試料とした。(Sample) 50 samples of human serum were used as samples.

(測定方法) 日立自動分析装置7150形を表4に示す条件下で使用し
て、測定を行った。
(Measurement method) Hitachi automatic analyzer 7150 was used under the conditions shown in Table 4 for measurement.

(測定結果) 2種類の試料を用いて、測定値の再現性について検討し
た結果を表5に示す。
(Measurement Results) Table 5 shows the results of examining the reproducibility of measured values using two types of samples.

表5の結果から明らかな如く、良好な再現性を示した。 As is clear from the results in Table 5, good reproducibility was exhibited.

また、豚腎臓由来のγ−GTPを添加した7%牛アルブ
ミン水溶液を用いて、検量線を作成したところ、約6400
lU/lまで良好な直線性が得られることが判った。
Moreover, when a calibration curve was prepared using a 7% bovine albumin aqueous solution to which γ-GTP derived from pig kidney was added, a calibration curve of about 6400 was obtained.
It was found that good linearity was obtained up to 1 U / l.

比較例3. (試液の調製) 緩衝液(R1) 比較例2で調製したものを使用した。Comparative Example 3. (Preparation of Reagent) Buffer (R1) The one prepared in Comparative Example 2 was used.

基質液(R2) 比較例2で調製したものを使用した。 Substrate solution (R2) The one prepared in Comparative Example 2 was used.

(試料) 実施例7と同じものを使用した。(Sample) The same sample as in Example 7 was used.

(測定方法) 表4のCHEMISTRY PARAMETERSの内、K FACTORを7123(ε
=9.5)へ変更した以外は、実施例7と同様の条件で測
定を行った。
(Measurement method) Of CHEMISTRY PARAMETERS in Table 4, set K FACTOR to 7123 (ε
= 9.5), the measurement was performed under the same conditions as in Example 7.

比較例4. (試液) スカンジナビア臨床化学会勧告法(SSCC法)に従って、
以下のものを使用した。
Comparative Example 4. (Test solution) In accordance with the Scandinavian Society of Clinical Chemistry Recommendation Method (SSCC method),
The following were used:

緩衝液(R1) 0.125Mトリス−塩酸緩衝液(pH7.8,at37℃、96mMグ
リシルグリシン及び13mM塩化マグネシウム含有)。
Buffer solution (R1) 0.125 M Tris-hydrochloric acid buffer solution (pH 7.8, at 37 ° C, containing 96 mM glycylglycine and 13 mM magnesium chloride).

基質液(R2) 20mMのγ−L−グルタミル−4−ニトロアニリドを含有
する0.1N塩酸溶液。
Substrate solution (R2) A 0.1N hydrochloric acid solution containing 20 mM γ-L-glutamyl-4-nitroanilide.

(試料) 実施例7と同じものを使用した。(Sample) The same sample as in Example 7 was used.

(測定方法) 表4のCHEMISTRY PARAMETERSの内、K FACTORを6835
(ε=9.90)へ変更した以外は、実施例7と同様の条件
で測定を行った。
(Measuring method) Of CHEMISTRY PARAMETERS in Table 4, K FACTOR is 6835
The measurement was performed under the same conditions as in Example 7 except that (ε = 9.90) was changed.

第1図に、実施例7で得られた各人血清の測定値と比較
例3で得られたそれとの相関関係を示す。尚、統計処理
により得られた相関係数、回帰直線式等を以下に示す。
FIG. 1 shows the correlation between the measured value of each person's serum obtained in Example 7 and that obtained in Comparative Example 3. The correlation coefficient, regression line equation, etc. obtained by the statistical processing are shown below.

検体数 n=50。Number of samples n = 50.

相関係数 γ=0.9998。Correlation coefficient γ = 0.9998.

回帰直線式(X:比較例3、Y:実施例7) Y=1.087X−0.038 平均値:比較例3=106.72、実施例7=115.94。Regression linear equation (X: Comparative Example 3, Y: Example 7) Y = 1.087X-0.038 Average value: Comparative Example 3 = 106.72, Example 7 = 115.94.

第2図に、実施例7で得られた各人血清の測定値と比較
例4で得られたそれとの相関関係を示す。尚、統計処理
により得られた相関係数、回帰直線式等を以下に示す。
FIG. 2 shows the correlation between the measured value of each person's serum obtained in Example 7 and that obtained in Comparative Example 4. The correlation coefficient, regression line equation, etc. obtained by the statistical processing are shown below.

検体数 n=50。Number of samples n = 50.

相関係数 γ=0.9998。Correlation coefficient γ = 0.9998.

回帰直線式(X:比較例4、Y:実施例7) Y=0.985X+2.603 平均値:比較例4=115.02、実施例7=115.94。Regression linear equation (X: Comparative example 4, Y: Example 7) Y = 0.985X + 2.603 Average value: Comparative example 4 = 115.02, Example 7 = 115.94.

第1図及び第2図より明らかな如く、本発明化合物を基
質として用いたγ−GTP測定試薬により得られた測定
値は、γ−L−グルタミル−p−ニトロアニリドを基質
として用いるSSCC法及びγ−L−グルタミル−3−カル
ボキシ−4−ニトロアニリドを基質として用いる従来法
により得られた測定値と良好な相関関係が得られること
が判る。
As is clear from FIGS. 1 and 2, the measured values obtained by the γ-GTP measuring reagent using the compound of the present invention as the substrate are the SSCC method using γ-L-glutamyl-p-nitroanilide as the substrate and It can be seen that a good correlation can be obtained with the measured value obtained by the conventional method using γ-L-glutamyl-3-carboxy-4-nitroanilide as a substrate.

[発明の効果] 本発明は、γ−GTP活性測定用基質として有用な新規
なγ−L−グルタミル−4−ニトロアニリド誘導体とこ
れを用いるγ−GTP活性測定法を提供するものであ
り、本発明化合物から成るγ−GTP活性測定用基質は
水溶性で溶解後の安定性が良く、基質としてのγ−GT
Pとの反応性も良く、しかも由来の異なるγ−GTPと
の反応性の差も小さい等基質として優れた特性を有する
点に顕著な効果を奏するものである。
EFFECTS OF THE INVENTION The present invention provides a novel γ-L-glutamyl-4-nitroanilide derivative useful as a substrate for γ-GTP activity measurement, and a γ-GTP activity measurement method using the same. The substrate for γ-GTP activity measurement comprising the compound of the invention is water-soluble and has good stability after dissolution, and γ-GT as a substrate
It has a remarkable effect in that it has excellent properties as a substrate such as good reactivity with P and small difference in reactivity with γ-GTP of different origin.

【図面の簡単な説明】[Brief description of drawings]

第1図は、実施例7で得られた各人血清の測定値と比較
例3で得られたそれとの相関関係を示すものであり、横
軸は比較例3で得られた値、縦軸は実施例7で得られた
値を夫々示す。 第2図は、実施例7で得られた各人血清の測定値と比較
例4で得られたそれとの相関関係を示すものであり、横
軸は比較例4で得られた値、縦軸は実施例7で得られた
値を夫々示す。
FIG. 1 shows the correlation between the measured value of each person's serum obtained in Example 7 and that obtained in Comparative Example 3, in which the horizontal axis represents the value obtained in Comparative Example 3 and the vertical axis represents Indicates the values obtained in Example 7, respectively. FIG. 2 shows the correlation between the measured value of each human serum obtained in Example 7 and that obtained in Comparative Example 4, in which the horizontal axis represents the value obtained in Comparative Example 4 and the vertical axis represents Indicates the values obtained in Example 7, respectively.

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】一般式 (式中、Rは、2以上の水酸基を有していてもよい低級
ヒドロキシアルキル基を表わす。)で示されるγ−L−
グルタミル−4−ニトロアニリド誘導体。
1. A general formula (In the formula, R represents a lower hydroxyalkyl group which may have two or more hydroxyl groups.) Γ-L-
Glutamyl-4-nitroanilide derivative.
【請求項2】一般式 (式中、Rは、2以上の水酸基を有していてもよい低級
ヒドロキシアルキル基を表わす。)で示されるγ−L−
グルタミル−4−ニトロアニリド誘導体を基質として用
いるγ−グルタミルトランスペプチダーゼ活性測定方
法。
2. General formula (In the formula, R represents a lower hydroxyalkyl group which may have two or more hydroxyl groups.) Γ-L-
A method for measuring γ-glutamyl transpeptidase activity using a glutamyl-4-nitroanilide derivative as a substrate.
JP63164716A 1987-07-03 1988-07-01 Novel .GAMMA.-L-glutamyl-4-nitroanilide derivative and method for measuring .GAMMA.-GTP activity using the same Expired - Lifetime JPH0627111B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP63164716A JPH0627111B2 (en) 1987-07-03 1988-07-01 Novel .GAMMA.-L-glutamyl-4-nitroanilide derivative and method for measuring .GAMMA.-GTP activity using the same

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP62-166642 1987-07-03
JP16664287 1987-07-03
JP63164716A JPH0627111B2 (en) 1987-07-03 1988-07-01 Novel .GAMMA.-L-glutamyl-4-nitroanilide derivative and method for measuring .GAMMA.-GTP activity using the same

Publications (2)

Publication Number Publication Date
JPH01110654A JPH01110654A (en) 1989-04-27
JPH0627111B2 true JPH0627111B2 (en) 1994-04-13

Family

ID=26489711

Family Applications (1)

Application Number Title Priority Date Filing Date
JP63164716A Expired - Lifetime JPH0627111B2 (en) 1987-07-03 1988-07-01 Novel .GAMMA.-L-glutamyl-4-nitroanilide derivative and method for measuring .GAMMA.-GTP activity using the same

Country Status (1)

Country Link
JP (1) JPH0627111B2 (en)

Also Published As

Publication number Publication date
JPH01110654A (en) 1989-04-27

Similar Documents

Publication Publication Date Title
CA1311333C (en) Aminoluciferin derivatives, processes for the production thereof and their application in the determination of enzyme activities
US4281181A (en) Novel L-γ-glutamyl-3-carboxy-4-hydroxyanilide and salts thereof
US4167449A (en) Composition and method for determining transferase and protease activity
IL43735A (en) Derivatives of gamma-glutamyl-4-nitroanilide and process for the preparation thereof
US4209459A (en) Novel L-leucyl-4-hydroxyanilide derivatives
JPS6111219B2 (en)
US5750359A (en) Composition for detecting leucocyte and proteinase in urine and its measuring device
JP2701090B2 (en) Oxidizable color reagent
JPH0627111B2 (en) Novel .GAMMA.-L-glutamyl-4-nitroanilide derivative and method for measuring .GAMMA.-GTP activity using the same
US4605614A (en) Method for measuring plasmin
US4851572A (en) γ-L-glutamyl-4-nitroanilide derivatives and process for determining γ-GTP activity using the same
US4816562A (en) Novel substrate for plasma kallikrein and a method for measuring biological components using the same
US4379764A (en) Phenylalanylarginine derivatives, process for producing same and method for measuring activity of enzymes using same
JPH0549280B2 (en)
Baker et al. Irreversible Enzyme Inhibitors. CVII. 1 Proteolytic Enzymes. II. 2 Bulk Tolerance within Chymotrypsin-Inhibitor Complexes
Kotake et al. Studies on amino acids. III. The synthesis of α-hydroxytryptophan
JPS6327467A (en) Gamma-glutamyl-4-nitroanilide derivative and determination of gamma-glutamyl transpeptidase activity using same
JPH0244519B2 (en)
JPS6332348B2 (en)
JP2009242246A (en) Method for producing color-developing compound by oxidation
US5792619A (en) Assay using oxidative chromogenic reagent
JPH0525199A (en) Tripeptide derivative and method for measuring activity of angiotensin transferase using the same
JP2003081934A (en) Method for producing 4-nitroaniline derivative
JPH0324061A (en) Novel oxidizable color reagent
JP2885536B2 (en) Tolan derivatives